BioCentury
ARTICLE | Company News

Proteonomix Inc., University of Miami deal

December 5, 2011 8:00 AM UTC

Proteonomix and the university will conduct a clinical study to test UMK-121 in patients with end-stage liver disease. The university will pay expenses associated with the study and the company will ...